Non-Current Liabilities
Total Liabilities
Biogen Total Liabilities decreased by 0.1% to $305.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 97.2%, from $11.05B to $305.10M. Over 5 years (FY 2020 to FY 2025), Total Liabilities shows a downward trend with a -53.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
A rising trend may indicate aggressive expansion or liquidity pressure, while a declining trend suggests deleveraging and improved balance sheet health.
Detailed definition
This represents the aggregate sum of all current and non-current financial obligations owed by the company to external p...
Peer comparison
Used across all industries to assess the overall debt burden relative to equity and assets.
Metric ID:
total_liabilitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.26B | $12.93B | $12.92B | $12.39B | $13.22B | $12.09B | $11.17B | $10.81B | $10.70B | $13.71B | $12.05B | $11.35B | $10.92B | $11.95B | $11.33B | $11.05B | $10.70B | $11.00B | $305.30M | $305.10M |
| QoQ Change | — | -2.5% | -0.1% | -4.1% | +6.7% | -8.6% | -7.6% | -3.2% | -1.1% | +28.2% | -12.2% | -5.7% | -3.9% | +9.5% | -5.2% | -2.5% | -3.2% | +2.8% | -97.2% | -0.1% |
| YoY Change | — | — | — | — | -0.3% | -6.5% | -13.6% | -12.8% | -19.1% | +13.5% | +7.9% | +5.0% | +2.0% | -12.8% | -5.9% | -2.6% | -2.0% | -8.0% | -97.3% | -97.2% |
Range$305.10M – $13.71B
CAGR-54.8%
Avg YoY Growth-15.6%
Median YoY Growth-6.2%
Current Streak2 quarters decline
Total Liabilities at Other Companies
Frequently Asked Questions
- What is Biogen's total liabilities?
- Biogen (BIIB) reported total liabilities of $305.10M in Q1 2026.
- How has Biogen's total liabilities changed year-over-year?
- Biogen's total liabilities decreased by 97.2% year-over-year, from $11.05B to $305.10M.
- What is the long-term trend for Biogen's total liabilities?
- Over 5 years (2020 to 2025), Biogen's total liabilities has grown at a -53.4% compound annual growth rate (CAGR), from $13.93B to $305.30M.
- What does total liabilities mean?
- The total amount of money the company owes to all creditors and stakeholders.